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Abstract 
Background: Adverse Drug Events (ADEs) at care transition expose patients to susceptible 
harm. Lack of medication reconciliation is a major factor leading to ADEs. It is highly 
important to apply medication reconciliation at care transitions to minimize medication 
discrepancies and reduce medication errors. Some patients are at higher risk due to 
medication errors: those with chronic diseases and poly-pharmacy, elder patients, those with 
other co-morbid factors and patients who are admitted to certain surgical procedure. 
Aim:The study aims to assess prevalence and factors associated with medication 
discrepancies at admission to surgical operation in hospitals using the Electronic Medical 
Record (EMR) system and to analyze the factors associated with medication discrepancies. 
Method: A prospective cross-sectional observational design was employed. The study was 
done in Jericho Governmental Hospital. The inclusion criteria was all patients who were 
aged ≥18 years old, who were admitted for any surgical operation in the hospital at least for 
24 hours and underwent major surgery. Data were collected in the period between the 
middle of July to the end of September, 2016, over a period of 75 days. All patients who 
were admitted to surgical operation and met the criteria were included. 
Findings : A total of 145 patients who satisfy the criteria were included, 19.3% of them had 
at least one medication discrepancy, 93% of these discrepancies were unintentional.  
Moreover,  93% of the discrepancies were omission of certain medication at time of 
admission,  20.7% of discrepancies occurred in patients taking 1-2 medications prior to 
admission and 7.6% in patients taking 3 or more medications. Logistic regression showed 
significant association between medication discrepancy and having a chronic disease 
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(Exp(B) = 12.910, P <0.001), and with the number of medication consumed prior to 
admission (Exp (B) = 23.953, P <0.001). 
 
Conclusion:  
The risk of medication discrepancy was higher in patients with chronic disease and poly-
pharmacy. The most frequent medication discrepancy was omission of certain medication 
consumed prior to admission. Therefore, medication reconciliation should be carried out for 
susceptible patients who have chronic diseases or consuming medication regularly at time of 
admission. Moreover, medication discrepancies may occur at any care transition other than 
admission, so it is highly important to perform medication reconciliation at any care 
transition.   
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  التسىيات الذوائية للورضى الوذخليي للاقسام الجراحية: دراسة في هستشفى اريحا
 اعذاد: هحوذ ابراهين "هحوذ رشيذ" عتيلي
 اشراف: د. هعتصن حوذاى
 هلخص الذراسة
الاعشاض اٌعىس١خ ٌلادٚ٠خ اٌزٟ رحذس عٕذ أزمبي اٌّش٠ط ِٓ ِسزٜٛ خذِخ لاخش رعشض اٌّشظٝ  خلفية الذراسة:
ٌه ٕ٘بن ظشٚسح وج١شح ٌخطش دٚائٟ ِحزًّ. ٠عزجش غ١بة اٌزسٛ٠بد اٌذٚائ١خ عبِلا سئ١س١ب فٟ حذٚس ٘زح الاعشاض. ٌٚز
ٌزطج١ك اٌزسٛ٠بد اٌذٚائ١خ ٌٍزمٍ١ً ِٓ حذٚس اٌفشٚلبد اٌذٚائ١خ ٌذٜ اٌّشظٝ ٚاٌحذ ِٓ حذٚس الاخطبء اٌذٚائ١خ. ثعط 
اٌّشظٝ ِعشظ١ٓ اوثش ِٓ غ١شُ٘ ٌلاخطبء اٌذٚائ١خ8 اٌٚئه اٌز٠ٓ ٠عبْٔٛ ِٓ اِشاض ِضِٕخ ٚ٠زٕبٌْٚٛ ِجّٛعخ ِٓ 
ٝ اٌز٠ٓ ٠عبْٔٛ ِٓ ِجّٛعخ ِشبوً صح١خ رسبُ٘ فٟ ص٠بدح اٌخطٛسح عٍٝ ح١برُٙ الادٚ٠خ، اٌّشظٝ اٌّسٕ١ٓ، اٌّشظ
 ٚاٌّشظٝ اٌز٠ٓ ٠ذخٍْٛ ِٓ اجً اٌزذخً اٌجشاحٟ ٌعلاجُٙ.
رٙذف ٘زٖ اٌذساسخ ٌزم١١ُ ِذٜ أزشبس اٌفشٚلبد اٌذٚائ١خ ٌذٜ اٌّشظٝ اٌّذخٍ١ٓ لاجشاء رذخً جشاحٟ  هذف الذراسة:
ٚرحذ٠ذ اٌعٛاًِ اٌزٟ لذ رسبُ٘ فٟ حذٚس ِثً ٘زٖ اٌفشٚلبد فٟ اٌّسزشف١بد اٌزٟ رسزخذَ ٔظبَ اٌٍّفبد اٌطج١خ الاٌىزشٟٚٔ 
  اٌّؤثشح. اٌّحٛسجٌٛزحٍ١ً اٌعلالخ ث١ٓ اٌفشٚلبد اٌذٚائ١خ ٚاٌعٛاًِ
اعزّذد اٌذساسخ ِٕٙج١خ اٌٛصف اٌزحٍ١ٍٟ. اجش٠ذ اٌذساسخ فٟ ِسزشف  ٝاس٠حب اٌحىِٟٛ. اعزّذد اٌّٛاصفبد  الونهجية:
سٕخ اٚ اوثش، اْ ٠ىْٛ اٌّش٠ط ِذخلا لاٞ رذخً  68اٌزبٌ١خ لادخبي اٌّشظٝ فٟ اٌذساسخ8 اْ ٠ىْٛ عّش اٌّش٠ط 
ً اٌجشاحٟ رذخلا جشاح١ب سئ١س١ب. رُ جّع اٌج١بٔبد فٟ اٌفزشح اٌٛالعخ سبعخ عٍٝ الالً ٚاْ ٠ىْٛ اٌزذخ 24جشاحٟ ٌّذح 
٠َٛ. وً اٌّشظٝ اٌز٠ٓ شٍّزُٙ اٌذساسخ اسزٛفٛا  35ٌّذح  4814ٚحزٝ ٔٙب٠خ شٙش ا٠ٍٛي  4814ص ٛث١ٓ ِٕزصف رّ
  الادخبي اٌّحذدح لاجشاء اٌذساسخ. ششٚغ
% ِٓ ٘ؤلاء اٌّشظٝ حذس ٌذ٠ُٙ فشق دٚائٟ 1.78ِش٠عب اسزٛفٛا اٌششٚغ اٌلاصِخ.  328شٍّذ اٌذساسخ  النتائج:
% ِٓ ٘زٖ 17% ِٓ ٘زٖ اٌفشٚلبد وبٔذ ثشىً غ١ش ِذسن ِٓ لجً اٌطج١ت. اظبفخ اٌٝ رٌه، 17ٚاحذ عٍٝ الالً، 
% ِٓ ٘زٖ اٌفشٚلبد حذثذ ٌذٜ 5.14اٌفشٚلبد صٕفذ وحزف احذٜ الادٚ٠خ اٌزٟ ٠زٕبٌٚٙب اٌّش٠ط ٚلذ الادخبي. 
ادٚ٠خ فبوثش.  1% حذثذ ٌذٜ اٌّشظٝ اٌز٠ٓ ٠زٕبٌْٚٛ 4.5دٚاء ٚاحذ اٚ دٚائ١ٓ لجً الادخبي ٚ ٌّشظٝ اٌز٠ٓ ٠زٕبٌْٚٛ 
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اثٕبء رحٍ١ً اٌج١بٔبد ثبسزخذاَ الأحذاس اٌٍٛج١سزٟ ظٙش ٕ٘بن علالخ ٚاظحخ ِّٚٙخ ث١ٓ اٌفشٚلبد اٌذٚائ١خ اٌزٟ رحذس 
اٌّش٠ط ٚوزٌه ِع عذد الادٚ٠خ اٌزٟ  ٚٚجٛد ِشض ِضِٓ ٌذٜ )100.0<P(.ٚلذ ادخبي اٌّش٠ط لالسب  َاٌجشاحخ   
 ٠زٕبٌٚٙب اٌّش٠ط لجً الادخبي
٠ضداد خطش حذٚس اٌفشٚلبد اٌذٚائ١خ فٟ حبي ٚجٛد اِشاض ِضِٕخ ٌذٜ اٌّش٠ط ٌٚذٜ اٌّشظٝ اٌز٠ٓ الخلاصة:
ف احذٜ ٠زٕبٌْٚٛ وّ١بد اوجش ِٓ الادٚ٠خ عٕذ اٌذخٛي ٌٍعٍّ١بد اٌجشاح١خ. اٌغبٌج١خ اٌعظّٝ ِٓ ٘زٖ اٌفشٚلبد وبٔذ حز
الادٚ٠خ اٌزٟ ٠زٕبٌٚٙزب اٌّش٠ط لجً الادخبي. ٚثزٌه فبْ رطج١ك اٌزسٛ٠بد اٌذٚائ١خ ٠جت اْ ٠طجك ٌٍّشظٝ الاوثش عشظخ 
ٌٙزٖ اٌفشٚلبد خصٛصصب اٌز٠ٓ ٠عبْٔٛ ِٓ اِشاض ِضِٕخ ٚ٠زٕبٌْٚٛ عذح ادٚ٠خ ثشىً ِٕزظُ ٠ِٛ١ب. علاٚح عٍٝ رٌه، 
ٍّش٠ط ِٓ ِسزٛ  ٜخذِخ غج١خ اٌٝ اخش ٌٚ١س فمػ ٚلذ اٌذخٛي ٌٍّسزشفٝ، اٌفشٚلبد اٌذٚائئ١خ رحذس عٕذ اٞ أزمبي ٌ
 ٚثٕبء عٍ١ٗ ٠ٕصح ثزطج١ك ٌجزسٛ٠بد اٌذٚائ١خ عٕذ اٞ ٌحظخ أزمبي ٌٍّش٠ط.
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Chapter one 
Introduction 
 
1.1 Back ground 
Medication errors are common at transition of care. Adverse Drug Events (ADEs) are the 
most common medication errors at care transition. Care transition occur when the patient is 
admitted to the hospital from emergency department, transferred from one level of care to 
another level or discharged from hospital. At the point of care transition medication 
discrepancies occur and lead to ADEs (Sullivan et al., 2005).  
Incomplete medication history at time of admission contr ibutes to Up to 27% of all 
hospital prescribing errors (Dobrzanski et al., 2002).  An interest about identification and 
correction of medication discrepancies and errors at the time of admission is growing 
among healthcare safety practices (medication reconciliation).  
At the time of hospital admission, accurate medication histories are considered important 
part of medication safety. First, they may reveal reasons for adverse drug events. Second, 
errors in me11dication history can lead to inappropriate drug therapy during hospital stay. 
Third, computerized physician order entry (CPOE) systems may be unable to detect errors. 
For example, CPOE systems would not be capable of detecting unintentional omissions of 
medications taken before admission without coded databases about previous medications 
consumed by patients.  
Medication Reconciliation is designed to prevent medication discrepancies at care 
transition, and thus minimize ADEs. Medication reconciliation is a process by which a 
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complete medication history is documented at any care transition, forming a list of all 
medication, and then the mediation history is compared with the admission medication 
orders and discharge order list. The core of medication reconciliation is collecting the Best 
Possible Medication History (BPMH) at admission and preparing the Best Possible 
Medication Discharge Plan (BPMDP) at discharge (Ketchum et al,. 2005). 
Medication reconciliation should take place at any level of care transition. Physicians, 
nurses and pharmacists are responsible for collecting the BPMH. Many researches 
indicated that clinical pharmacists are highly encouraged to be responsible for the process 
of medication reconciliation (NPSG, 2006). 
The Joint Commission international (JCI) on Accreditation of Healthcare Organizations 
(JCAHO) defines medication reconciliation as "the process of comparing a patient‘s 
medication orders to all of the medications that the patient has been taking". This 
reconciliation is done to avoid medication errors such as omissions, duplications, dosing 
errors, or drug interactions. At each transition of care in which new medications are 
ordered or existing orders are rewritten medication reconciliation should be performed. 
Transitions in care include changes in setting, service, practitioner or level of care (NPSG, 
2006). 
1.2 Problem statement 
Based on the above information, about medication reconciliation at hospital admissions 
assessment of outcomes and risk factors for medication discrepancies, and the impact of 
their use on human health care, the researcher studied the risk factors for medication 
discrepancies at hospital admission. 
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ADE in patients at care transition exposes patients to susceptible harm. Lack of medication 
reconciliation is a major factor that can lead to these ADE. It is very important to apply 
medication reconciliation at care transitions to minimize medication discrepancies and 
reduce medication errors. Some patients are at higher risk due to medication errors: those  
with chronic diseases and those consuming more than one medication, elder patients, those 
with other co-morbid factors, and patients who are admitted to certain surgical procedure 
where the focus is on the surgical intervention. Many factors contribute to the absence of 
medication reconciliation in health organizations. These factors include: absence of 
organization buy- in and leadership, absence of Standard Operation Procedures (SOPs), 
absence of patient‘s engagement in the process and low awareness of medical staff about 
medication reconciliation 
1.3 Justification of the study 
Most health care facilities today are operating with limited resources, including financial 
and staffing limitations. A sound project plan helps to identify roles, responsibilities, and  
staff resources. A strong business case outlines the financial incentives for the facility. 
Examples of two models to calculate potential gross savings of a newly designed or 
improved medication reconciliation process are provided. Specifically, the first model 
demonstrates a cost benefit analysis of reducing preventable adverse drug events (ADEs); 
the second model demonstrates a cost benefit analysis of the use of pharmacists or other 
staff to perform medication reconciliation. 
Jericho Hospital was chosen as example of MoH hospitals to be the target of this study 
since that MoH is the main provider for secondary health services (45% of total hospitals 
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with 1579 beds and 204527 admissions).  Moreover, MoH operates 63.1% of general 
hospitals beds and 43.4% of specialized hospitals beds. In addition to that, the MoH runs 
specialization residency program. 
1.4  Significance 
In some countries 67% of admitted patients encounter at least one or more discrepancies 
occur on admission, transfer and discharge (Sullivan et al, 2005). Medication discrepancies 
are due to omission or commission of some medications and vary in their level and 
severity (Sullivan et al., 2005). Although most of these discrepancies are harmless and few 
are harmful, some of the ADEs caused by medication discrepancies are fatal. 
Medication reconciliation is being considered as a solution to decrease ADEs and 
minimize medication errors. Hospital-based medication reconciliation practices have been 
adopted as a patient safety solution by the World Health Organization (WHO) in the World 
Alliance for Patient Safety launched by Pan American Health Organization (PAHO).  
The report of Institute of Medicine entitled ‗‗to err is Human: Building a Safer Health 
System‘‘, published in 2000, stressed the significant  health and economic consequences 
that drug adverse events and medication errors cause in the healthcare settings. Medication 
Reconciliation is one of the Joint Commission‘s National Patient Safety Goal and the 
WHO high 5s project to enhance patient‘s safety by minimizing medication errors (NPSG, 
2006). The Institute for Healthcare Improvement (IHI) (in the United States) and Safer 
Healthcare Now (in Canada) have made medication reconciliation a top priority.  
In Palestine, patient safety has been considered the heart of healthcare quality. The 
growing complexity of healthcare systems and the evidence of incidents that harm patients 
show the need to make healthcare safer in Palestinian hospitals. 
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A study by Hamdan about assessment of patient safety culture in Palestinian public 
hospitals in 2013 concluded that implementation of quality improvement strategies; 
including accreditation in hospitals is positively associated with patient safety. The 
Palestinian public hospitals survey results reveal that staff fee ls less positive toward patient 
safety culture within their organization. Several dimensions of patient safety culture need 
to be improved, especially those related to developing effective incident reporting system 
and establishing a non-punitive culture, allocating more staff and adequate work hours and 
ensuring hospital management support for patient safety. The survey should be repeated 
after implementation of appropriate interventions to monitor improvements in patient 
safety culture in these hospitals (Hamdan, 2013) 
A study in Palestine by Najjar in 2015 emphasized the idea that a more positive patient 
safety culture is associated with lower adverse events in hospitals at the departmental 
levels. Further analysis should include a more representative sample to examine the causal 
relationship between patient safety culture and adverse events incidents. The results 
showed that, as expected, relationships exist between safety culture and the rate of adverse 
events at departmental level. Almost all of the relationships tested were in the expected 
direction. Eight (57 %) of the 15 relationships were statistically significant (p < 0.05, p < 
0.01), indicating that departments with a more positive patient safety culture had lower 
rates of adverse events in their department (Najjar S. et al, 2015). 
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1.5 Aim and objectives 
1.5.1 General objective 
To assess prevalence and factors associated with medication discrepancies at admission to 
surgical operations in a hospital using the Electronic Medical Record (EMR) system. 
1.5.2  Specific objectives 
 To determine the prevalence of medication discrepancies at admission to the hospital 
surgical operation  
 To determine the type of reconciliation error caused by discrepancies. 
 To analyze the factors (patient and organizational) that might be associated with 
medication discrepancies 
 To correlate medication discrepancies outcomes to the independent variables. 
1.6 Limitation of the study 
The main limitations of the study are those related to the patient including 
1- Lack of comprehensive and integrated health information system  
2- Potential recall bias, where the patient is unable to remember certain medications 
3- Inability of the patient or family member to identify the name, dose and frequency 
of certain medications. 
4- Patient‘s possible reluctance to report certain medications ex. Those medications 
related to sexual dysfunction.  
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Chapter Two 
Literature review 
2.1 Introduction 
A review of the literature identified implementing a medication reconciliation system can 
substantially decrease the number of medication errors that occur at the interfaces of 
patient care and therefore increase patient safety. The main core topics discussed in this 
chapter provide a foundation for this research are patient safety, medication reconciliation 
and medication discrepancies. 
The first topic of the literature review is an inquiry into patient safety as it pertains to 
medication safety. Although, this topic is not new by any means, it is important to 
understand the history and dynamics of why healthcare has come to focus strongly on the 
patient safety movement and specifically on medication safety in the past decade. This 
review identifies patient safety issues related to adverse drug events or medication errors, 
identifies the deficits in the medication process, and establishes the need for a medication 
reconciliation system. 
The second topic examines how a medication reconciliation system enhances patient 
safety. It builds a case for medication reconciliation, discusses the positives and negatives 
of such a system along with lessons learned in hospitals that have implemented such a 
system. The implementation of a medication reconciliation system will need the 
collaboration of numerous healthcare professionals within the hospital. 
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2.2 Patient safety as it pertains to medication safety 
Healthcare professionals are dedicated to providing safe quality care that is evidence-based 
and of high clinical standards. However, even with the most efficient and conscientious 
healthcare professional, things can go wrong and mistakes do occur. The International 
Council of Nurses (2005) identifies every step in patient care in today‘s complex health 
system has the potential for error and holds some degree of risk to patient safety. The 
Canadian Nurses Association (2005) agrees health care systems are prone to error and 
failure, and the risk of adverse events is significant. 
The critical issues of medical errors and patient safety have been moving up the list of 
priorities not only for healthcare professionals and administrators, but also for the public, 
the media and policy makers (IHI, 2005).  
Kohn, Corrigan & Donaldson published the report ―To Err is Human‖ (2000) to create the 
catalyst needed for the patient safety movement of today. The report analyzed the available 
evidence on patient safety and concluded that healthcare is really not as safe as it should 
be. Wachter (2004) points out that before the report was released, society‘s mental model 
for medication errors was directly related to one person‘s  mistake, a way of thinking 
reinforced by the medical and nursing programs. The culture in healthcare at the time was 
extremely punitive. It treated errors as moral issues in isolation of other factors, which led 
only to sporadic reporting. Wachter (2004) concluded the lack of a system‘s approach in 
determining the root causes of medication errors placed minimal pressure one executives, 
educators or policy makers to focus on or invest in patient safety. Residents taking multiple 
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medications and the complexity of managing those medications make medication 
reconciliation an important safety issue (TJC, 2012). 
Kohn, Corrigan & Donaldson (2000) estimated, ―over 770,000 patients are injured and as 
many as 44,000 to 98,000 patients die as a result of medical errors in hospitals each year 
and up to 7,000 hospital deaths are directly attributable to preventable medication errors‖. 
Several studies in the United Kingdom and Australia provided a clearer picture of the 
impact of adverse events in their hospitals. The Australian data clearly demonstrated that 
adverse events in healthcare were a major public health problem (Wilson, Harrison, 
Gibberd, & Hamilton, 1999). A United Kingdom‘s pilot study indicated 53% of 
preventable adverse events occurred in general medical/surgical wards (Vincent, Neale, & 
Woloshynowych, 2001). Although there is minimal Canadian data on adverse events in 
hospitalized patients, Hunter & Bains (1999) in their Ontario study found that 16,344 
admitted patients suffered an adverse drug reaction and each year 680 or 4.2% of those 
patients died (p. 35).  Beglaryan & Wong (2004) found the per capita rate of adverse 
events is similar to the US. They suggest adverse drug events claim 5,000 to 10,000 lives 
every year in Canada. Forster, Asmis, Clark et al.  (2004) found 12.7% of admitted patients 
to an Ottawa teaching hospital suffered an adverse event and that 38% of those were 
preventable. The released national study of patient safety in Canadian hospitals estimates 
that 7.5% of adults admitted to hospital experienced one or more adverse events in 2000 
and that 37.3% of these were preventable (Baker et al., 2004). Even though this national 
study suggests care in Canadian hospitals is safe for the vast majority of patients, 
unfortunately, some patients still experience preventable injuries and complications related 
to their care. 
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Clear, standard and common definitions are important factors in the understanding of 
patient safety, adverse events, medication errors and their impact across the continuum of 
care. The definitions and the interpretations of these issues fluctuate depending on the 
study or the focus of the research. The following definitions most accurately reflect the 
concept of patient safety and adverse events in the healthcare environment that is the 
subject of this research. 
The Canadian Patient Safety Dictionary (2003) defines patient safety as, "the reduction and 
mitigation of unsafe acts within the health care system, as well as through the use of best 
practices shown to lead to optimal patient outcomes". The Disease Management 
Association of America (as cited in Bennett, 2005) also defines patient safety as ―...the 
prevention of harm to patients ...., with the aim to reduce errors of commission or 
omission‖. The Institute of Medicine (1999) definition of patient safety encompasses the 
processes that protect patients from injury caused by medical mismanagement. 
Fundamentally, patient safety is about continually working towards avoiding, managing 
and treating unsafe acts within the healthcare system (Health Canada& Patient Safety Fact 
Sheet, 2004). 
2.3 Adverse drug events and medication discrepancies 
Adverse events are ―unintended injuries or complications to a patient caused by health care 
management, rather than by the patient‘s underlying disease, which prolongs the 
hospitalization and/or produces disability at the time of discharge‖ (Baker et al., 2004). 
Medication errors remain one of the most costly medical errors, often resulting in patient 
death (TJC, 2012). 
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The Agency for Healthcare Research & Quality (2005) defines an adverse drug event as 
―an adverse event involving medication use‖ (Para 3). Furthermore, Runciman, Roughead, 
Semple & Adams (2003) believe that adverse drug events ―encompass both harm that 
results from the intrinsic nature of a medication as well as harm that results from 
medication errors associated with the manufacture, distribution, or use of medicines 
including those that result from under-use of medicines or failure to prescribe a medicine 
when indicated‖. The most common type of adverse event is an adverse drug event or a 
medication error which is an injury resulting from medical intervention related to a drug 
(Hughes & Ortiz, 2005). Examples of adverse drug events include wrong dose, wrong 
drug, wrong technique, wrong patient, wrong time, and wrong route, faulty of drug 
distribution systems, verbal and written miscommunications and poor packaging and 
labeling of medications. 
The literature on patient safety and adverse drug events make reference to ‗active‘ and 
‗latent‘ failures. Beglaryan & Wong (2004) and Reason (2000) define active failures as 
unsafe acts that are committed by healthcare professionals who are in direct contact with 
the patient or the system, such as picking up the wrong syringe or misreading instructions. 
Latent failures are weaknesses of a system to identify and catch adverse events before they 
cause harm. These systems weaknesses include heavy workloads, stressful environments 
and inadequate communication. By themselves latent failures are often quite subtle but 
when combined with active failures can result in catastrophic adverse events (Reason, 
2000). 
Kohn et al. (2000) agree many adverse drug events or medication errors are system-related 
and not attributable to individual negligence or misconduct. Research shows between 80 
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and 200 steps may be associated with the administration of a single dose of medication in 
an acute care setting, beginning when the physician prescribes the medication, to when the 
pharmacy dispenses it to, and to when the nurse administers it to the patient. Sullivan, 
Gleason, Rooney, Groszek & Barnard (2005) agree the medication process is multifaceted 
and involves all disciplines: physician (prescriber), pharmacist (verification, preparation 
and dispensing), nurse (validation, administration and monitoring) and patient (receiver of 
the medication). 
As healthcare delivery systems become more complex, the potential for adverse drug 
events and medication errors increases. Rozich & Resar (2001) found there are certain 
points of care or interfaces in which medication errors tend to happen more frequently. 
They found that approximately 60% of errors occurred when patients were admitted, 
transferred to another ward or discharged. Cornish and Gleason also found in their 
literature reviews that variances between medications patients were taking prior to 
admission and their admission orders ranged from 30-70% and the most common 
discrepancy cited was the unintentional omission of a home medication. As well, 
according to IHI (2005), poor communication of medical information at transition points is 
responsible for as many as 50% of all medication errors and up to 20% of adverse drug 
events in hospitals. Forster, Shojania & Van Walraven (2005) similarly found that 
over12% of patients experienced an adverse drug event within 2 weeks of discharge. 
This confirms that adverse events and mistakes happen across the entire continuum of care 
and a systems design is needed to minimize the incidence of mistakes and enhance patient 
safety. 
13 
 
In designing a systems approach to medication safety, the challenges faced by 
organizations include: no clear ownership of the medication process, no standardized 
guidelines on how to obtain a medication history, competing demands for time that may 
result in the medication history being given a low priority, lack of knowledge and 
understanding by front- line staff of the importance of obtaining an accurate medication 
history. As well, there are many situations where patients are poor or not in a position to 
list the names of their home medications (Safer Healthcare Now, 2005b). 
The study of Sullivan et al. 2005 revealed discrepancies between medication histories and 
documented orders on more than half of the patients. Medications omitted by the 
prescriber accounted for more than 40% of the discrepancies requiring intervention. 
Frequency, dosing, and route of medications accounted for more than 30% of discrepancies 
(Sullivan et al., 2005). 
In healthcare, there is the potential for many safety errors, but medication errors remain the 
most common. Almost half of medication errors are a result of inadequate medication 
reconciliation practices (Barnsteiner, 2008). In a pharmacy study evaluating discrepancies 
and the types of medications involved for patients transitioning from the hospital to the 
long-term care setting, researchers found that almost 75% of admissions and 21% of 
medications had medication discrepancies (Martin, 2012). 
It is estimated that on average, at least one medication error occurs per hospital patient per 
day, with at least 1.5 million preventable errors committed annually (National Academy of 
Sciences, 2006). According to Maanen et al. (2011), the most severe consequences of 
medication omission or inaccuracy have led to elevated blood pressures, chest pain and 
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reoccurrence of psychiatric symptoms. Clarification of resident medications is often 
required as they transition throughout the health care system. Long-term care residents are 
often transferred to acute care settings or other health care settings creating the possibility 
for medication discrepancies. In appropriate reconciling of routine medications can lead to 
inaccurate documentation of medication dosages, routes and indications for use. These 
discrepancies can lead to implementation of inaccurate medications leading to resident 
harm. 
Medication discrepancies are common at admission to hospital. Patients who are admitted 
to surgical operations are at high risk of such discrepancies. González et al, 2015 
conducted a study that aimed to determine the prevalence of reconciliation errors (REs) at 
admission to surgery departments. They found that 55.1% had ≥1 RE. Omission of certain 
medication was the most frequent RE (84.1%). They concluded that patients receiving 
larger number of drugs before admission are at higher risk to have REs 
Hospital admissions can result in many medication errors. Many of these errors are 
unintended. Cornish et al, 2005 conducted a study on patients who used at least regular 
prescription medications before they were admitted to hospital. They reported that 53.6% 
had at least 1 unintended discrepancy. 46.4% of these discrepancies were omission of a 
regularly used medication. Tam et al, 2005 reviewed previous studies and found that 27%–
54% of patients had at least 1 medication history error. 10%– 61% had at least 1 omission 
error (deletion of a drug used before admission) and that 19%–75% of the discrepancies 
were unintentional.  
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When the information is incomplete or inaccurate, there is a gap in the continuity of care 
and increased risk to the patient. One solution is the medication reconciliation system, a 
process for collecting and documenting a complete list of each patient‘s medications on 
hospital admission and those prescribed during the hospital stay (JCAHO, 2005). 
2.4 Medication Reconciliation 
Medication reconciliation is defined as the formal process of obtaining a complete and 
accurate list of each patient‘s current home medications (including any over-the counter-
medications and herbal treatments) and then comparing the physician‘s admission, transfer 
and/or discharge orders to that list (IHI, 2005). When any inconsistencies are revealed 
through this process, they are brought to the physician‘s attention and if necessary, changes 
are made to the orders (IHI, 2005; JACHO, 2005; Safer Healthcare Now, 2005b). 
Medication reconciliation is seen as the most effective solution for reducing adverse drug 
events and medication errors (IHI, 2005). It is a process of creating as accurately as 
possible a list of all the medications a patient is currently taking at home and using this list 
as a resource as the patient weaves their way through the healthcare system. Reconciling 
medications involves matching the patient‘s list of existing medications w ith the 
physician‘s admission, transfer, and discharge orders. Presently, there is no organized way 
of determining what medications the patient is taking at home and often this information is 
scattered across numerous forms and places on the patient‘s hosp ital chart. The advantages 
of medication reconciliation include: (a) accurate comparison of home medications to 
those ordered on admission to hospital, (b) promotion of continuity of care and (c) 
prevention of medications from being missed from home to hospital. Through the 
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medication reconciliation process, the healthcare provider obtains the best possible 
medication history and compares this with admission medication orders. 
Each time a patient moves from one care setting to another, staff need to review previous 
medication orders along with the new orders and plans for care. Prior to discharge, the 
medications ordered during hospitalization are compared with those ordered for use at 
home. Discrepancies between the medication history and hospital orders are clarified with 
the physician. The process is designed in a standardized and systematic manner to ensure 
complete and accurate reconciliation. Rozich & Resar (2004) reported, ―This improvement 
process promotes seamless communication among the patient‘s caregivers and appropriate 
medication therapy to avoid inadvertent duplications or omissions‖. Therefore the 
proposed result is that the right patient receives the right medication, in the right dose, at 
the right time along the continuum of care. 
The literature confirms that using a medication reconciliation process at each patient 
transition point of care can decrease the number of medication errors and more importantly 
can prevent patient harm. Rozich & Resar (2004) found that a series of interventions in the 
reconciliation process introduced over a seven-month period successfully decreased the 
rate of medication errors by 70% and reduced adverse drug events by over 15%. In another 
study, the utilization of pharmacy technicians to initiate the reconciling p rocess for 
scheduled surgical patients reduced adverse drug events by 80% within three months of 
implementation in an American hospital (Michels & Meisel, 2003). Rozich & Resar (2001) 
believe that a successful reconciling process can also reduce work and re-work of nurses, 
pharmacists, and physicians associated with the management of medication orders. 
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During transition of care, inaccurate medication reconciliation is associated with increased 
risk of adverse events for patients. Older adults are the population most often affected by 
medication errors, and long-term care facilities struggle to accurately document medication 
reconciliation. Errors are more common at hospital discharge, but the critical moment for 
detecting and resolving them is during hospital or long-term care admission (Stover, A. L., 
2016). 
At the heart of the medication reconciliation system is the development of a tool for 
reconciling medications at admission, identifying discrepancies, and capturing 
documentation that will significantly reduce the need for nurses and pharmacists to contact 
physicians for clarification. A challenge that is faced in many hospitals is the fragmented 
nature of our health care system (Marriott & Mable, 2002). The sources of information on 
medications are scattered in a number of different forms and places in the patient chart. 
Physicians hold some of the information in the patient‘s chart in their offices, so it is not 
readily accessible in the hospital. The pharmacists have some information, but only for the 
prescriptions they have filled. It does not include any over the counter drugs, herbal 
treatments or adjustments the physician makes to medications that do not require 
prescription. The patient‘s hospital record may be incomplete, depending where the care 
was initiated (ambulatory care, emergency, post-surgery), the patient may not know what 
they are taking and a single drug may have several different names (chemical name, brand 
name, generic name). Nurses are often the ones who start the medication process by 
gathering medical information, the physician writes the orders and the pharmacist often 
reviews the medication regimen. Although, these tasks are all interdependent and often 
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conducted in isolation, each healthcare professional must accept accountability and 
responsibility for their part in the system. 
Strong leadership, accountability and commitment are needed in order to move the 
medication reconciliation system forward. It will require fundamental changes in the way 
hospitals and healthcare professionals currently work. Nurses, pharmacists and physicians 
in hospitals must begin to work collaboratively, and silos need to be replaced by 
interdisciplinary teams. All members of the patient care team need to be involved in the 
process of medication reconciliation. No single group - nurses, pharmacists or physicians - 
should be responsible for ensuring that medication reconciliation works (IHI, 2005). 
Involve staff members early in the change process to help with knowledge transfer and 
introduction of the tools necessary to sustain the new process. 
Dalton et al. (2010) conducted a study at Joseph Medical Center after implementing an 
improved medication reconciliation document a reduction in discharge medication 
reconciliation errors was noted from 5% to less than 1%. Three hundred seventy-seven 
patients were enrolled in a study conducted by Ziaeian, Araujo, Van Ness, & Horwitz, 
(2012); findings noted that of a total of 22.3% of admission medications were re-dosed or 
stopped at discharge. Of these, 24.2% were classified as suspected provider errors. 
Excluding suspected errors, patients had no understanding of 69.3% of re-dosed 
medications, 81.6% of stopped medications, and 62.0% of new medications. Altogether, 
307 patients 81.4% either experienced a provider error or had no understanding of at least 
one intended medication change. Providers were significantly more likely to make an error 
on a medication unrelated to the primary diagnosis than on medication related to the 
primary diagnosis odds ratio 95%, confidence interval 2.65. 
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Medication reconciliation errors occur across transitions in patient care (Duran-Garcia et 
al., 2012). ―Twenty-two percent of preventable medication reconciliation errors occur 
during admissions, 66 percent during transitions in care, and 12 percent during discharge‖ 
(Santell, 2006). National Priorities Partnership, (2010) estimates that medication errors 
total nearly $16 billion each year. As of January 1, 2006 the Joint Commission required all 
hospitals to have a procedure in place for reconciling patient medications across the 
continuum of care (Wortman, 2008). Of all medication errors in a hospital, 25% in 
hospitalized patients are caused by a failure to reconcile new prescriptions with ongoing 
home treatments (Duran-Garcia et al., 2012). 
Medication errors continue to exist across all transitions of patient care (Duran-Garcia et 
al. 2012). Improving patient safety through medication reconciliation is only a small 
component of endeavors needed to improve the quality of care delivered in lo ng-term care 
settings. Developing programs and projects designed to promote accuracy in medication 
reconciliation practices keeps patients safe, improve patient outcomes and reduces health 
care costs (Wortman, 2008). 
2.5. Interdisciplinary Collaboration 
The challenge of patient safety in complex environments such as acute care hospitals 
requires a multi- faceted approach and the involvement of all key stakeholders in the 
healthcare system (IHI, 2005). Meeting these demands requires health professionals to 
work in partnership with each other, as well as with other professionals such as risk 
managers, and with patients in order to provide safe quality care. Since nurses and 
pharmacists do not have the authority to change medication therapy without a physician‘s  
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order, it is essential they work collaboratively with physicians and other allied health 
professionals to develop a clear understanding of common and diverse issues and goals, 
while at all times keeping patient safety as the common link. The need for teamwork and 
collaboration has been clearly established throughout the literature on patient safety (IHI, 
2005; JACHO, 2005; Safer Healthcare Now, 2005b). 
Katzenbach & Smith (as cited by Penn State University, 2006) define team as, ―A small 
number of people with complementary skills who are committed to a common purpose, 
performance goals and approach for which they are mutually accountable‖ (Para 2). 
Healthcare organizations are accountable and responsible for creating and maintaining 
environments in which safety becomes the foundation for all decisions affecting patient 
care, making it simpler for healthcare providers to do no harm and ensure patient safety. 
With the launch of the Canadian Patient Safety Institute and the Safer Healthcare Now 
Campaign, patient safety is now receiving growing and much needed attention (Safer 
Healthcare Now, 2005a). Orchard, Curran &Kabene (2005) believe that such a shift will 
move decision-making to the level of practice that can directly impact patient safety. This 
will require efforts at the individual, team, institutional, educational and government levels 
to move this collaborative effort forward. 
The lack of supporting technology and information systems is a commonly cited barrier to 
implementing patient safety initiatives, encouraging collaborative processes and system 
wide restructuring of resources (Bates, 2000; Bayley, Savitz, Rodriquez, Gillanders& 
Stoner, 2005). The Canadian Coordinating Office for Health Technology Assessment 
(2004) found ―technologies such as computerized provider order entry, clinical decision-
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making support tools, automated dispensing, bar codes for drug dispensing and 
computerized medication administration records all decrease medication error rates‖ (p. 1). 
However, technologic tools such as computerized provider order entry are only as accurate 
as the healthcare workers using them. Bates (2000) confirms ―the best medication 
processes will thus not replace people but will harness the strengths of information 
technology and allow people to do the things best done by people, such as making complex 
decisions and communicating with each other‖. 
The advances in telecommunications and information technology will increase the ease of 
information transfer across different settings and healthcare providers br inging consistency 
and coordination to the medication process. Clinical information technology will enable 
workflow changes that streamline medication processes and make it easier for clinical 
professionals to work together, communicate and share their pro fessional expertise 
(McKesson Corporation, 2003). This in turn will create opportunities for increased inter-
disciplinary collaboration to provide safer, patient care. Clinical information technology 
will assist to improve the quality of care and medication safety by ensuring a standardized 
process is being used across the continuum of care (McKesson Corporation, 2003). In 
addition, these advances will ultimately result insignificant change, assist in knowledge 
transfer and eventually produce a culture shift in healthcare. 
2.6 Summary 
Providing safe and high quality care to patients is an increasing priority across all levels of 
healthcare, and government systems. Adverse drug events or medication errors are a 
complex issue and can occur as a result of variety of factors within the healthcare system. 
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The majority of adverse events or medication errors result from unsafe systems rather than 
individual incompetence. 
Medication reconciliation is identified as the most effective solution for reducing the 
number of medication errors at each transition point as the patient moves across the 
continuum of care (IHI, 2005; Safer Healthcare Now, 2005b). Reconciling medications is a 
systematic process that develops an up-to-date, medication profile for all healthcare 
providers‘ reference during patient‘s admission, transfer and discharge while in hospital. 
Any discrepancies or inconsistencies found by comparing this profile against the 
physicians written admission orders are brought to the attention of the physician. 
Medication reconciliation along with good communication, shared decision-making 
involving an interdisciplinary team and the patient is crucial to preventing adverse drug 
events. Adverse drug events and medication errors in acute care facilities are common, 
costly and often preventable (IHI, 2005; Safer Healthcare Now, 2005b). Medication safety 
is a complex issue, although many healthcare professionals with responsibility for 
medication safety improvements have experiences with different phases of the medication 
process, rarely have they been brought together to establish a comprehensive medication 
safety process which covers the continuum of care. Medication reconciliation has been 
identified as a key factor in promoting patient safety and reducing medication errors as 
patients move from one level of care to another. 
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Chapter 3 
Conceptual framework 
3.1 Theoretical framework of the study 
Medication reconciliation is defined as ― the process of creating the most accurate list 
possible of all medications a patient is taking — including drug name, dosage, frequency, 
and route — and comparing that list against the physician‘s admission, transfer, and/or 
discharge orders, with the goal of providing correct medications to the patient at all 
transition points within the hospital‖ (IHI). 
3.2 Conceptual framework of the study 
As show in figure 3.1 the dependent variable is the reconciliation errors (REs) that will be 
detected during the reconciliation process by the pharmacist. REs will be communicated to 
the responsible provider (physician) to identify its type whether it is intentional or 
unintentional. The attributable factors will be those factors related either to the patient: age, 
sex and medical history, smoking habit and number of medications, or those related to the  
characteristics of the organization:  type of admission (emergency or planned), surgical 
operation and admitting physician (resident or specialist). 
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Figure 3.1 Conceptual framework 
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3.3 Conceptual definitions 
Discrepancies– ―Any difference between the chronic medication consumed before 
hospital admission and the medication prescribed in hospital‖ (González-García et al 
2015). Joint Commission on Accreditation of Healthcare Organizations classified these 
discrepancies, and Delgado Sanchez considered discrepancies that were not justified by the 
attending physician as Reconciliation Errors (Sanchez 200). 
Number of medications: the number of many drugs that are administered to t or 
consumed by patient at the same time  
Intentional discrepancy – ―Any intended difference in patient‘s medication made by the 
provider and documented in the patient‘s EMR‖ 
Unintentional discrepancy – ―Any difference that was made in patient‘s medication and 
not intended by the provider or intended but not documented‖ 
3.4. Operational definitions  
3.4.1. Dependent variable: includes the medication discrepancies (intentional and 
unintentional) 
3.4.2. Independent variables: 
 Patient’s characteristics: 
- Gender (Male / Female) 
- Age (15-30, 31-50, 51-83) 
- Past medical history 
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 Type of surgery  
- General  
- Urology  
- Orthopedic  
- ENT 
- Obstetrics and Gynecology 
 Type of admission 
- Emergency 
- Planned 
 Provider characteristics 
- Specialist 
- Resident 
 Previous chronic disease 
- No chronic disease 
- At least one chronic disease 
 Number of medications 
- No medications 
- 1-2 medications 
- ≥ 3 medications 
 
 
 
27 
 
 Discrepancy type 
- None  
- Intentional 
- Non-intentional 
- Both  
 Medication error 
- Omission of a pre-admission prescription medication 
- Incorrect addition of a medication not part of the patient‘s pre-admission                                                                              
regimen (commission) 
- Different dose 
- Different route 
- Different frequency 
- Different medication (within the same drug class) 
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Chapter Four 
Methodology 
 
4.1 Introduction 
The study aims to assess prevalence and factors associated with medication discrepancies 
at admission to surgical operation in a hospital using the Electronic Medical Record 
(EMR) system, to identify the type (intentional or unintentional) of these discrepancies and 
to analyze the factors (care provider, patient, and organizational) that might be associated 
with medication discrepancies 
 
4.2 Study design 
A prospective cross-sectional observational design was employed. Patients studied when 
they were admitted to any surgical operation in the hospital over a period of time.  A 
pharmacist was involved in applying medication reconciliation standard operation 
procedures (SOPs) within the first 24 hours of patient‘s admission and through the period 
of stay in the hospital until discharge. The pharmacist collected the best possible 
medication history (BPMH) and compared it with the admission medication orders (AMO) 
by the provider at admission.  
 
     The Best Possible Medication History (PBMH) was obtained from multiple sources 
including patients, family members, old prescription medication lists, discharge 
information on the patients‘ medications from recent hospital admissions; patient‘s records 
form primary health care (PHC) centers and contacts with community pharmacies and 
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physicians. At least two sources were used to obtain the BPMH and the patient himself or 
one of his companions from which the history was collected through an interview should 
be the main and mandatory source. The PBMH then was compared with Admission 
Medication Orders (AMO) for medications prescribed by the provider at the time of 
admission. Then, the discrepancies between PBMH and AMO were identified. 
 
The pharmacist documented all discrepancies. After that the pharmacist reviewed the 
results collected to identify the type of reconciliation error (intentional or unintentional). 
The data was analyzed to identify the prevalence, risk factors, type and level of medication 
error. 
4.3 Classification of medication errors and potential harm assessment 
 Medication errors were classified by type of error: omission of a pre-admission 
prescription medication, incorrect addition of a medication not part of the patient‘s pre-
admission regimen (commission), different dose, different route and different frequency or 
different medication (within the same drug class).  
Any discrepancy was documented and any undocumented discrepancy was considered a 
medication error.  
4.4 Target population 
The study setting is Jericho governmental hospital in the West Bank. The study targeted 
surgery department in the hospital. Average surgical operation is 160 monthly. Jericho 
Hospital was chosen because of many reasons. Jericho Hospital is a general second ary 
hospital where many types of surgery operations are being performed, including general 
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surgery, gynecology and obstetrics, urology, orthopedic and ENT surgery. Furthermore the 
study needed a direct clinical interaction between the researcher and the patient or the 
family and the providers and full access to the patient‘s medical record and the researcher 
has the privilege and authority to do so in Jericho Hospital according to the laws of MoH. 
In addition, Jericho hospital serves not only patients who are resident in Jericho district but 
also those patients from other districts ex Hebron, Ramallah, Tubas, Nablus and Jerusalem 
districts. Finally, Jericho Hospital is applying the WHO Patient Safety Friendly Hospital 
Initiative since few years. 
4.5 Sample of the study 
The targeted population is patients admitted to the surgical operation. Admission to the 
hospital and undergoing surgery itself is a risk. So we tried to target all patients who met 
the selection criteria as much as possible. Criteria that make the patient eligible to 
participate are: 
1- Age of  18 years and older 
2- Undergoing major surgery 
3- Admitted for at least 24 hours  
 
4.5.1 Sample type and size 
The sample of the study was a convenient sample that targeted all patients who were 
admitted to any surgical operation and met the eligibility criteria. The researcher tried to 
include these patients as much as possible. The sample size was around 145. This sample 
was enough to perform the study according to the average number of surgery operations 
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performed in the hospital and the previous studies about the same topic. (Gonzalez Garcia, 
2005) 
4.6 Study period  
The study was carried from over 75 days from the middle of July to the end of September 
2016, a period of time that was enough to meet the needed sample size. 
 
4.7 Instruments 
 Interview 
Data collected by interviews with patients, companions and caregivers to obtain BPMH. 
An interview questionnaire was used to standardize the process. 
 
 Types of medication  
Types of medication noted on the BPMH included ALL prescribed (based on the advice of 
prescriber) and non-prescribed medications (not based on prescriber‘s advice): 
• prescribed (medications the patient is instructed to take by the prescriber)  
• non-prescribed (the prescriber did not advise the patient to take the medication)  
• prescription medication 
• Non-prescription medication (e.g., over-the counter (OTC)) 
• Complementary or herbal medication 
• Recreational drugs 
• ‗PRN (i.e., ―as needed‖) medication 
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4.8 Data collection 
 Creation of the BPMH  
Requires use of a systematic process for obtaining a medication history by:  
1. Interviewing patients and/or family where possible. 
 2. Verifying and documenting the history. 
If a patient or family is unable to participate in a medication interview, other sources may 
be utilized to obtain medication histories and/or to clarify conflicting information. These 
sources include patient‘s previous medical record within the same hospital or other MoH 
hospitals linked to the electronic information system, previous medical records from other 
private providers and patient‘s record in primary healthcare center. Other sources should 
never be a substitute for a thorough patient and/or family medication interview where it is 
possible. 
 EMR revision  
The EMR was reviewed to identify the Admission Medication Orders (AMO) at the time 
of admission. Then discrepancies between BPMH and AMO were documented on the form 
used. 
4.9 Validation of the tool 
The form used to collect data was obtained from previous studies and was modified to 
accommodate the organization structure. The form was sent to two surgeons and four 
clinical pharmacists for validation. All responded that the form was applicable and valid. 
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4.10 Data sources  
Data were obtained from the patient himself or one of the accompanying family members 
if the patient is unable to provide information about his or her medications, patient‘s 
medical record on the hospital, patient‘s previous medical record on other MoH hospitals 
documented in the EMR applied in MoH hospitals and patient‘s medical record in PHC or 
other providers when possible. 
At least two sources were used to collect data and the patient or family member was one of 
these sources. 
4.11 Data analyses 
Descriptive analysis: Distribution of medication discrepancies among the different 
independent variables used in the study were measured and summarized the data results as 
tabulated description, graphics and statistical explanation. 
Inferential analysis: Univariate and multivariate correlation analysis were used to identify 
the relation between gender, age group, admission type, admitting physician, surgery 
department, concomitant chronic disease and poly-pharmacy with the existence of 
medication discrepancies. Then the relation between the independent variable (medication 
discrepancies) and discrepancy type and the type of medication error was identified. 
Multivariate analysis was used to identify the relation between different variables and the 
outcome (SPSS) V 18 (Released 2009. PASW Statistics for Windows, Version 18.0. 
Chicago: SPSS Inc). 
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4.12 Ethical considerations 
 Ethical approval was obtained from Al-Quds University – School of Public 
Health review board to conduct the study 
 Ethical approval from Ministry of Health through the General Directorate of 
Health Education and the General Directorate of Hospitals. A permission 
letter was sent from School of Public health at Al-Quds University and an 
approval letter was received from the general directorate of health 
Education MoH through the General Directorate of Hospitals, a copy was 
sent to the general director of Jericho Hospital to facilitate the research. 
 Patients included in the study were told about the research and they had the 
choice to be enrolled or not during the interview. A verbal consent was 
obtained from all patients  
 Revision of patient‘s medical record is already ethical since it is part of the 
tasks performed by the researcher pharmacist during daily work activity 
according to MoH job description and specifications.  
 Confidentiality was assumed during the study. The only identification code 
that was used during the study is the patients electronic file number which is 
used to review the patient‘s EMR. 
 There was no conflict of interests in the study. 
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Chapter Five 
Results 
5.1 Introduction 
The researcher included 145 patients in the study. All the patients included in the study 
were admitted to a surgery department in the hospital and met the eligibility criteria of the 
study.  
5.2 Descriptive Analyses  
5.2.1 Characteristics of the patients 
As shown in Table 5.1, 35.2% of the patients were males. Almost half of the patients 
(47.6%) were between 31 and 50 years old, 37.9% were between 18-30 years old. The 
majority (83.4%) were nonsmokers. Emergency admissions accounted for 6.2% of the total 
admissions while planned admissions were 93.8%. General surgery amounted 40.7%, 
followed by Obstetrics and Gynecology 24.8%, orthopedic 15.2%, urology 11%, and ENT 
was 8.3% of the total surgery types performed. With regard to admission, 95 (65.5%) of 
the patients were admitted by a resident physician, while 50 (34.5%) were admitted by a 
specialist. Patients with past chronic disease history represented 18.6% of the patients. 
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Table 5.1: Demographic characteristic of patients (N=145) 
Variable Frequency (%) 
Gender  
Male 51 (35.2) 
Female 94 (64.8) 
Age group  
18-30 55 (37.9) 
31-50 69 (47.6) 
51-83 21 (14.5) 
Smok ing habit  
Smoker 24 (16.6) 
Non smoker 121 (83.4) 
Admission type  
Emergency 9 (6.2) 
Planned 136 (93.8) 
Surgical operation  
General 59 (40.7) 
Urology 16 (11) 
Orthopedic 22 (15.2) 
E.N.T 12 (8.3) 
Obstetrics and Gynecology 36 (24.8) 
Admitting physician  
Resident 95 (65.5) 
Specialist 50 (34.5) 
Chronic disease  
No chronic disease 118 (81.4) 
Have at least one chronic disease 27 (18.6) 
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Figure 5.1 Age group                                              Figure 5.2 Gender 
 
Figure 5.3 Admission type                                   Figure 5.4 Surgical operations 
 
Figure 5.5 Admitting physician                             Figure 5.6 Chronic disease 
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5.2.2 Prevalence and type of discrepancies  
Table 5.2 shows that 104 (71.7%) patients was not taking any medication regularly prior to 
admission, 30 (20.7%) patients were taking 1-2 medications and 11 (7.6%) were taking 3 
or more medications. Among the 41 patients taking medication regularly before admission, 
28 (19.3%) of them had medication discrepancy at time of admission, whereas 26 (93%) of 
these discrepancies were unintentional. The most common unintentional discrepancy 
(93%) was omission of certain pre-admission medication. 
Table 5.2: Prevalence and type of discrepancies 
Variable Frequency (%) 
Number of medications  
None 104 (71.7) 
1-2 medications 30 (20.7) 
≥ 3 medications 11 (7.6) 
Discrepancy  
No discrepancy 117 (80.7) 
At least one discrepancy 28 (19.3) 
Discrepancy type  
Intentional 2 (7) 
Unintentional 26 (93 ) 
Medication error  
Omission 26 (93) 
Different rout 1 (3.5) 
Different medication 1 (3.5) 
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Figure 5.7 Number of medications                                      Figure 5.8 Discrepancy 
 
Figure 5.9 Discrepancy type                               Figure 5.10 Medication error 
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5.3 Inferential analysis 
5.3.1 Cross tabulation of discrepancy with independent variables  
The cross-table analysis (chi-square and fisher exact tests) in table 5.3 was conducted to 
test if the discrepancy is in relation or affected by the independent variables. . Whereas, 8 
(28%) of all males included in the study experienced at least one discrepancy compared to 
20 (72%) of females who experienced discrepancy. However, no statistically significant  
difference was observed among the two groups (p>0.05). Patients who are between 30-
51years had the highest prevalence of discrepancy (46.4%) followed by those who age 51-
83 years group had (35.7%) of total discrepancies and the difference was statistically 
significant (p<0.002). The majority of discrepancies were noticed in planned surgery 
(96.5%) of total discrepancies, no significant differences were observed. According to 
surgery type, almost half of discrepancies were in general surgery (43%),  and one third in 
obstetrics and gynecology (29%), urology surgery, orthopedic and ENT accounted for less 
than one third (28%) of total discrepancies collectively, yet these differences are not 
statistically significant (p>0.05). Although around two thirds of disc repancies (64%) 
resulted when patient is admitted by a resident physician, this was statistically insignificant 
(p>0.05). Patients with chronic diseases have higher ration of discrepancy than those who 
don't have (p<0.001). Lastly, patients taking 1-2 medications prior to admission had the 
majority of discrepancies (71.5%) compared to those taking 3 or more medications 
(28.5%), this difference between the two groups was statistically significant (p<0.001). 
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Table 5.3: Distribution of medication discrepancies 
Variable Discrepancy (% ) Chi square (x
2 p-value) 
Gender    
Male 8 (28) 0.663   (0.415) 
Female 20 (72) 
Age group    
18-30 5 (17.9) 12.830  (0.002)   Fisher exact 
31-50 13 (46.4) 
51-83 10 (35.7) 
Smok ing  
 
 
Nonsmoker 24 (0.86) 0.129 (0.486) 
Smoker  4 (0.14) 
Admission type    
Emergency 1 (3.5) 0.641   (0.451) Fisher exact 
Planned 27 (96.5) 
Type of surgery    
General 12 (43) 0.703  (0.974) Fisher exact 
Urology 2 (7) 
Orthopedic 4 (14) 
E.N.T 4 (14) 
Obstetrics and Gynecology 8 (29) 
Admitting physician    
Resident 18 (64) 0.023 (0.879) 
Specialist 10 (36) 
Chronic disease    
No chronic disease 9 (32) 55.514  (<0.001) 
Have at least one chronic disease 19 (68) 
Number of medications    
1-2 medications 20 (71.5) 87.266  (<0.001) Fisher exact 
≥ 3 medications 8 (28.5) 
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5.3.2 Logistic Regression: discrepancy error 
The aim of this analysis is trying to find the variables within the set of data which have an 
influence and effect on whether we will have a discrepancy error or not  within the patients 
admitted to surgical operations. The dependent variable was encoded to have either the 
value of NO or YES (having no discrepancy or having at least one discrepancy). 
While the independent variable are as follows: 
1. Age 
2. Sex ( male ,female) 
3. Admission  Type (Emergency , planned) 
4. Admission Physician (resident, specialist)  
5. Smoke (yes , no) 
6. Number of medications 
7. Chronic Record (yes, no) 
8. Surgical operation (5 different types) 
 
Thus, the logistic regression was applied since the dependent variable has two categories 
while we have many independent variables (continuous and categorical) as mentioned 
above. 
 
5.3.3 Sample size – ratio of cases to variables 
The minimum ratio of valid cases to independent variables for logistic regression is 10 to 
1, with a preferred ratio of 20 to 1. In this analysis, there are 145 valid cases and 7 
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independent variables and one categorical variable with 5 categories. The ratio of cases to 
independent variables is 145 to 11, which equals 13 to 1 which satisfies the minimum 
requirement.  
5.3.4 Overall relationship between independent and dependent variables  
The presence of a relationship between the dependent variable and combination of 
independent variables is based on the statistical significance of the model chi-square at 
after the independent variables have been added to the analysis. 
In this analysis, the probability of the model chi-square is (90.568) with P-value <0.0001 
which is less than or equal to the level of significance of 0.05 which indicates the exis tence 
of a relationship between the independent variables and the dependent variable was 
supported. As shown in table 5.4 
Table 5.4: Omnibus Tests of Model Coefficients 
 
Chi-
square Df Sig. 
Step 1 Step 90.568 11 0.0001 
Block 90.568 11 0.0001 
Model 90.568 11 0.0001 
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5.3.5 Numerical problems 
Multicollinearity in the logistic regression solution is detected by examining the standard 
errors for the b coefficients. A standard error larger than 2.0 indicates numerical problems, 
such as multicollinearity among the independent variables, table 5.5 shows a 
multicollinearity among the admission physician and the all the category of the surgical 
operation. So they had to be eliminated from the analysis. 
Table 5.5: Multicollinearity between variables 
 B S.E. Wald Df Sig. Exp(B) 
Age .024 .031 .633 1 .426 1.025 
Sex1 .856 1.131 .574 1 .449 2.355 
Smoke .435 1.151 .143 1 .705 1.545 
AdmType1 1.566 1.532 1.045 1 .307 4.788 
Surgical operation   .563 4 .967  
Surgical operation 
(1) 
-.651 3.121 .044 1 .835 .521 
Surgical operation 
(2) 
-2.108 2.990 .497 1 .481 .121 
Surgical operation 
(3) 
-.443 3.031 .021 1 .884 .642 
Surgical operation 
(4) 
-.766 3.683 .043 1 .835 .465 
Admitting 
Physician 
-1.191 2.931 .165 1 .685 .304 
Number of 
medications 
3.260 .748 18.971 1 .000 26.053 
Chronic disease 2.484 .895 7.696 1 .006 11.985 
Constant -6.310 3.674 2.949 1 .086 .002 
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5.3.6 Relationship of individual independent variables to dependent variable  
The probability of the Wald statistic significance for the following variables (Age, Sex, 
Admission Type, Admission Physician, Smoking, Surgery Department)  was more than or 
equal to the level of significance of 0.05 thus they should be eliminated from the analysis. 
While for Number of medications and the chronic disease was significant which have less 
than or equal to the level of significance of 0.05 thus they should be interred in to the final 
equation analysis.    
5.3.7 The Final Analysis 
By recalculating the equation including only the poly-pharmacy and the chronic disease 
variables, we have the probability of the model chi-square (74.34) with P-value <0.0001, 
less than or equal to the level of significance of 0.05 which means that there is difference 
between the model with only a constant and the model with independent variables and we 
don‘t have numerical problems as shown in table 8 (S.E. < 2). As shown in table 5.6 
Table 5.6: Multicollinearity among variables 
 
B S.E. Wald df Sig. Exp(B) 
Step 1 Number of 
medications 
3.176 .674 22.220 1 0.0001 23.953 
Chronic disease 2.558 .747 11.741 1 0.001 12.910 
Constant -4.177 .682 37.540 1 0.0001 .015 
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The value of Exp (B) for the number of medications was 23.963, which implies that a one 
unit increase in the number of medications increase the odds that study respondents have 
discrepancy by almost 24 times. While the value of Exp (B) for the Chronic disease was 
12.91, which implies that  having a chronic disease increase the odds that study 
respondents have discrepancy by almost 13 times. 
5.3.8 Classification using the logistic regression model: by chance accuracy rate  
The independent variables could be characterized as useful predictors distinguishing 
survey respondents who have actual adoption from survey respondents who have actual 
intention if the classification accuracy rate was substantially higher than the accuracy 
attainable by chance alone. Operationally, the classification accuracy rate should be 25% 
or more than the proportional by chance accuracy rate. 
The proportional by chance accuracy rate was computed by first calculating the proportion 
of cases for each group based on the number of cases in each group in the classification 
table. Table 5.7 shows that the proportion in the "No" group is 117/145 = 0.807. The 
proportion in the "Yes" group is 28/145 = 0.193.  
Table 5.7: Proportional by chance accuracy rate  
Observed 
Predicted 
Discrepancy  
Percentage 
Correct 
No 
discrepancy 
At least one 
discrepancy 
Discrepancy  No discrepancy 117 0 100.0 
At least one 
discrepancy 
28 0 .0 
Overall Percentage     80.7 
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Then, we square and sum the proportion of cases in each group (0.0.193² + 0.0.807² =   0. 
681).  0.681 is the proportional by chance accuracy rate. 
5.3.9 Criteria for accuracy classification  
The accuracy rate computed by SPSS was 91.0% (as in table 8) which was greater than or 
equal to the proportional by chance accuracy criteria of 85.1% (1.25 x 68.1% = 85.1%).  
The criteria for classification accuracy are satisfied.  
The model succeeded in predicting and classifying 91.0% of the discrepancy as dependent 
variable using the independent variables number of medications and the chronic disease as 
shown in table 5.8. 
Table 5.8: Accuracy rate 
  
Observed 
  
  
Predicted 
Discrepancy  
Percentage 
Correct 
No 
discrepancy 
At least one 
discrepancy 
Step 
1 
Discrepancy  No discrepancy 113 4 96.6 
At least one 
discrepancy 
9 19 67.9 
Overall Percentage     91.0 
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5.3.10discriminate analysis 
5.3.10.1 Medication errors 
Before trying to conduct the discriminate analysis, a simple frequency to the medication 
error type shows that only two options are valid to the analysis since the other options 
have a value zero or one. Then the logistic regression is more appropriate for the 
remaining two categories (Different route and Different medication) as shown in table 5.9 
Table 5.9: Frequency of medication error type 
 
Frequency Percent 
Valid 
Percent 
Cumulative 
Percent 
Valid None 117 80.7 80.7 80.7 
Omission 26 17.9 17.9 98.6 
Different route 1 .7 .7 99.3 
Different 
medication 
1 .7 .7 100.0 
Total 145 100.0 100.0  
 
By selecting the two options the result was as shown in table 5.10 
Table 5.10: Medication error type 
 
Frequency Percent 
Valid 
Percent 
Cumulative 
Percent 
Valid None 117 81.8 81.8 81.8 
Omission 26 18.2 18.2 100.0 
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Chapter Six 
Discussion, conclusion and recommendations 
6.1 Discussion 
According to our knowledge there is no research on medication reconciliation and 
discrepancies that occur at care transition in Palestine. Our study assessed medication 
discrepancies at admissions to surgical operations since we believed that these patients are 
at risk of medication discrepancies where the focus is on the surgical problems and patients 
might face medical consequences due to withdrawal of certain pre-operative and post-
operative medications Kennedy, J. M and colleges (2000). The study was carried in Jericho 
MoH hospital in the period between July 2016 and September 2016. The researcher aimed 
to determine the prevalence of medication discrepancies at admission to surgical operation, 
determine the type of error caused by discrepancies and analyze the factors (care provider, 
patient, and organizational) that might be associated with medication discrepancies. The 
main tool of the study is clinical interview of patients who were admitted to surgical 
operation. All patients who were admitted were 18 years and older and admitted to at least 
24 hrs to any surgical operations were interviewed. Our study did not aim to generalize the 
situation in surgical operations on other departments nor the situation in Jericho hospital on 
other hospitals.  
Among 145 patients who were included in the study, 41 of them were taking medications 
regularly prior to admission not related to surgery. Of these patients 19.3% had at least one 
discrepancy. A systematic review by Tam et al, (2005) identified 22 studies about errors in 
medication history. The review showed that 10%–67% of patients had at least one 
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medication history error which leads to medication discrepancy. In many countries 67% of 
admitted patients encounter at least one or more discrepancies occur on admission, transfer 
and discharge (Sullivan et al. 2005).  The prevalence of medication discrepancies shown in 
our study is consistent with the findings of the systematic review of previous studies about 
the same topic by Tam et al (2005) and Sullivan et al. 2005. This indicates that the 
situation in our study is similar to that in other studies and patients admitted to surgical 
operations may face same risks of reconciliation errors. Two of these studies reviewed by 
Tam et al (2005) included patients who were admitted to surgical operations. The first  
study was by Dodds, (1982) titled An objective assessment of the role of the pharmacist in 
medication and compliance history taking showed that mean 0.4 errors per patient when 
prescription and nonprescription medications were included in medication history. Also a 
study by Hocking et al (1998) titled Better drug history taking; an assessment of drugs 
mnemonic showed that 10% of patients had at least one discrepancy.  
 Moreover, our study showed that 93% of the discrepancies identified were unintentional 
and were not recognized or not documented by the provider. However, a study about 
medication discrepancies at time of admission by Cornish and colleagues (2005) showed 
that 53.6% of patient admitted to general internal medicine clinical teaching units had at 
least one unintended discrepancy. In addition, another study by Vira and colleagues (2006) 
about reconciliation differences at hospital admission and discharge showed that almost 
60% of patients had at least one unintended errors.  In consistence, a systemic review of 
previous studies showed that 19%–75% of the discrepancies were unintentional (Tam et al, 
2005).  Our findings are close to the findings of other studies in assessing the type of 
medication discrepancies Cornish and colleagues (2005), Vira and colleagues (2006). This 
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may be due to similarities in organization policy and procedures by physicians at time of 
admission in different sitting and different hospitals in many countries. The differences 
might be also caused by differences in documentation system and the healthcare member 
who obtained the history from the patient 
In addition, the result of our study showed that 93% of the discrepancies were omission of 
certain medications at time of admission. However, a González et al, 2015 study on 
medication reconciliation at admission to surgical operations showed that 84.1% of 
medication discrepancies were omission of medications consumed by the patient prior to 
admission. The result of our study is close to González study with a slight difference might 
be related to differences in documentation of some discrepancies and ignorance of certain 
medications at time of admission due to inability to recall these medications by the patient, 
which is one of the main limitations of the study.  
In our study, both univariate and multivariate analyses showed that no significant relation 
between any of the organization characteristics and medication discrepancies. Regarding to 
admitting physician, the result of our study is consistent with the results of a study by 
Susanna E. Bedell et al, 2000 which found that there was no increasing discrepancy in case 
of whether the physician involved was an intern or specialist. This may be due to 
similarities in admission procedures between resident and specia list physicians in different 
settings. On the other hand, regarding to the type of admission the results of our study 
contradicts the results shown by a González et al, 2015 study which showed that the risk of 
having discrepancies is much higher in case of elective admission than in emergency 
admissions. This contradiction between our study and the other study can be justified that 
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in our study 93.8% of admissions were planned while in González study it was only 
34.7%.  
In regards to patient‘s characteristics, univariate analysis showed that the age of the 
patient, having an accompanying chronic disease and the number of medications are the 
only patient‘s factors that were found significant determinants of medication discrepancies. 
Our result is supported by González et al, 2015 study which showed that patients with old 
age who receive larger number of medications prior to admission are at higher risk to have 
medication discrepancies. Another study by Susanna E. Bedell et al, 2000 showed that the 
two main predictor factors for medication discrepancies are age and number of medications 
consumed by patient prior to admission. This result confirms the results of our study which 
indicates that there is a significant relation between age and number of medications and 
medication discrepancies. This is consistent with our clinical knowledge that older age 
patients are at higher risk to have multi-chronic disease and larger number of medication 
being consumed.  Furthermore, in our study there was no significant relatio n between the 
gender of the patient and discrepancies. This result is the same as the results of a Susanna 
E. Bedell et al, 2000 study which showed that there was no increase in discrepancies when 
involving female patients. 
Multivariate analysis of the findings of patient‘s characteristics was necessary to avoid any 
confounding between variables because we thought that there is a significant relation 
between age, chronic disease and number of medications. The results showed that the most 
affecting factors that are associated with medication discrepancy were chronic disease 
history and number of medications. The exclusion of the age of the patient from the final 
logistic regression may be related to many factors such as differences in adherence to 
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medications between different age groups and involving other care givers and family 
members in the handling medications and recall of medications in the medication history. 
This is supported by a study by Ralph I. Horwitz,  Sarah M. Horwitz, 1993 which showed 
that older age patients have more compliance to chronic medications such as 
antihypertensive and congestive heart failure medications.  
In the same aspect, the results of our study showed that having a chronic disease prior to 
admission increases the opportunity to have a discrepancy by almost 13 times , whereas 
one increase in the number of medications prior to admission will increase the opportunity 
to have discrepancy by almost 24 times. Having chronic disease will increase the number 
of medications consumed by the patient and thus increase the opportunity of having 
reconciliation errors. This result is close to the results of a study by González et al, 2015 
which showed that any additional medication on the patient‘s regimen will increase risk of 
reconciliation errors by 1.34 folds. The difference between the values of the risk between 
the two studies might be due to variations in socioeconomic factors and literacy between 
the two samples and the availability of comprehensive and integrated EMR.  
6.2 Conclusion  
Medication discrepancies are common at all care transition settings. Discrepancies may 
occur in all types of medications. The majority of these discrepancies are unintentional. 
Although many of these medications are harmless, some may have serious health impacts 
on patients. 
Many factors contribute to the prevalence and type of discrepancies. The study showed that 
the most affecting factors that are associated with medication discrepancy were chronic 
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disease history and the number of medications. According to the results of the study, the 
risk of medication discrepancy was higher in patients with chronic disease and wit the 
increase in number of medications consumed by patient. Moreover, the most frequent 
medication discrepancy was omission of certain medication consumed prior to admission.  
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6.3 Recommendations 
 For MoH: 
- Applying medication reconciliation process at each care transition. 
- Involvement of clinical pharmacists in the process of medication reconciliation. 
- Establishing a comprehensive and integrated EMR to facilitate the communication 
of information between different care providers. 
- Encourage systematic information dissemination between providers.   
 
 For researchers: 
- Further investigation of medication discrepancies in other departments. 
- Evaluating the situation in other care transition sittings i.e. transfer and discharge. 
- Identifying health impacts for the discrepancies that occur at care transition. 
- Assessing the relation between discrepancies and socioeconomic factors. 
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Annexes 
Annex 1: study interview form 
Annex 2: Permission letters from hospitals 
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1. Age:  
2. Sex:                  Male             Female 
3. Smoking:        Yes              No 
4. Type of admission:             Emergency                    Planned            
5. Surgical operation:                   General                   Urology                          Orthopedic           
    ENT                Obstetrics and Gynecology 
6. Surgical procedure: 
_________________________________________________________________________
__________ 
7. Admission date:____/___/________  Discharge date: ____/____/_______  Hospitalization 
days: __________ 
8. Concomitant chronic diseases:              Hypertension               Cardiac disease  
     Diabetes                 Renal disease             Respiratory disease 
                        Other (please specify): ___________________________________________ 
 
PREADMISSION MEDICATION LIST VERIFICATION AND 
ORDER FORM      (Medication Reconciliation) 
PATIENT EMR No: 
 
DATE COMPLETED: 
 
TIME STARTED: 
 
TIM E FINISHED: 
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9. Admitting physician:             Resident                  Specialist 
10.  The patient handle medications himself:               Yes              No 
11.  Any handling problems:            Swallowing, crushing/splitting          
     Opening bottles or blisters                 Inhaling 
12.  Adherence to medications:            Yes                              No   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
67 
 
    LIST BELOW ALL OF THE PATIENT’S MEDICATIONS PRI OR TO ADMISSION INCLUDING OTC AND HERBAL  
MEDICATIONS (NEW MEDICATIONS OR MEDICATI ON CHANGES SHOULD BE WRITTEN ON ADMISSION 
ORDERS) 
Source of Medication list:  (check all used):                                            Allergies:  
 
Patient medication list                                                                                         No allergy                       
Patient/Family recall 
Pharmacy _________________                                                                                       Allergy to _ __________ 
Primary care physician list / PCHIS 
Physician order list 
Past Medication Administration Record from facility 
Other: _________________________________  
 
 
 
 
 
 
MEDICATION NAME 
(WRITE LEGIBLY) 
DOSE 
(mg, mcg, ) 
ROUTE 
(PO, GT, SC, IV) 
FREQUENCY 
LAST DOSE 
DATE/TIME 
Continued  
on  
Admission 
Discontinue 
on  
Admission 
Change 
Rationale for 
D/C or Change 
1.  
        
2.          
3.  
        
4.  
        
5.          
6.  
        
7.  
        
8.  
        
9.  
        
10.  
        
11.  
        
12.  
        
Check continue OR 
Discontinue OR Change 
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LIST BELOW ALL OF THE PATIENT‘S NEW MEDICATIONS ON ADMISSION (ADMISSION 
MEDICATION ORDERS AMO) COLLECTED FROM PATIEN‘S ADMISSION RECORD AND 
RESPONSIBLE PRESCRIBER OR TRANSCRIBER 
 
 
 
 
 
Other information from the interview 
___________________________________________________________________ 
 
 
Number of discrepancies after reconciliation: __________________ 
 
 
Completed by: _________________________________________          
 
Signature: _______________________________  
 
 
 
 
 
 
 
MEDICATION 
NAME 
(WRITE 
LEGIBLY) 
DOSE 
(Mg, 
mcg,) 
ROUTE 
(PO, GT, 
SC, IV) 
FREQ UEN
CY LAST DOSE 
DATE/TIME 
Rationale for 
Addition 
Order Type 
Prescribed Transcribed 
        
        
        
        
        
        
69 
 
 
 
70 
 
 
 
71 
 
 
 
 
